ICON Public (NASDAQ:ICLR) Releases FY24 Earnings Guidance

ICON Public (NASDAQ:ICLR) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $13.90-14.10 for the period, compared to the consensus estimate of $13.98. The company issued revenue guidance of $8.26-8.30 billion, compared to the consensus revenue estimate of $8.28 billion. ICON Public also updated its FY 2024 guidance to 13.900-14.100 EPS.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Redburn Atlantic assumed coverage on ICON Public in a research report on Monday, October 14th. They set a “neutral” rating and a $311.00 price objective for the company. Citigroup lowered their price objective on shares of ICON Public from $300.00 to $290.00 and set a “buy” rating on the stock in a report on Monday, January 6th. JPMorgan Chase & Co. reduced their target price on shares of ICON Public from $375.00 to $280.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Evercore ISI lowered their price target on shares of ICON Public from $360.00 to $350.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Finally, Barclays dropped their target price on ICON Public from $330.00 to $275.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. Four research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $287.00.

ICON Public Stock Down 0.1 %

ICON Public stock opened at $217.99 on Tuesday. The company’s 50-day moving average price is $211.31 and its two-hundred day moving average price is $270.81. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 0.35. The stock has a market cap of $17.98 billion, a P/E ratio of 24.30, a P/E/G ratio of 1.54 and a beta of 1.20. ICON Public has a twelve month low of $183.38 and a twelve month high of $347.72.

ICON Public (NASDAQ:ICLR) last announced its earnings results on Wednesday, October 23rd. The medical research company reported $3.35 earnings per share for the quarter, missing analysts’ consensus estimates of $3.72 by ($0.37). The firm had revenue of $2.03 billion for the quarter, compared to the consensus estimate of $2.13 billion. ICON Public had a return on equity of 11.91% and a net margin of 9.00%. ICON Public’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter last year, the business posted $3.10 EPS. As a group, analysts expect that ICON Public will post 13.42 EPS for the current year.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.